Advocacy Convergence in Medicine: Analyzing Legislative Priorities and Political Action Committee Overlap Among Major Medical Societies

PURPOSE: Advocacy in health policy involves a broad coalition of medical professionals, including physicians, advanced practice providers, and patient advocacy stakeholders. These advocacy efforts shape federal policies that directly influence urology practice, including procedural reimbursement, prior authorization, telehealth access, and surgical liability. Medical societies are key intermediaries between physicians and policymakers, yet the extent of alignment in advocacy priorities across organizations remains unclear. We evaluated convergence in legislative priorities, lobbying activities, and political engagement among major medical societies to contextualize urology advocacy within the broader health policy landscape. MATERIALS AND METHODS: This cross-sectional study analyzed advocacy efforts, legislative priorities, and Political Action Committee (PAC) contributions of ten U.S. medical and specialty societies from 2020-2024 using publicly available data from OpenSecrets, the Federal Election Commission, and organizational websites. Societies included the American Urological Association and nine other national medical societies selected based on national presence, advocacy activity, and clinical scope. Legislative priorities of each society were grouped into thirteen policy categories. Lobbying and PAC data were analyzed by agency targets, legislation, expenditures, and campaign recipients. RESULTS: All ten societies prioritized reducing administrative burdens, expanding telemedicine, supporting physician well-being, and advancing health equity. Most lobbied the Centers for Medicare & Medicaid Services and the Department of Health and Human Services in 2024. The American Medical Association reported the highest lobbying expenditures. PAC contributions across societies targeted legislators on the House Energy and Commerce, Appropriations, and Ways and Means Committees. CONCLUSIONS: Medical society advocacy agendas have substantial overlap, suggesting opportunities for coordinated efforts to shape health policies impacting payment structures, coverage decisions, and workforce sustainability in urology.